Caution in the Use of Immunohistochemistry for Determination of Cell of Origin in Diffuse Large B-Cell Lymphoma.
The Royal Marsden Hospital, London and Surrey, United Kingdom.
Mary
M
Gleeson
The Royal Marsden Hospital, London and Surrey, United Kingdom.
Eliza A
EA
Hawkes
The Royal Marsden Hospital, London and Surrey, United Kingdom david.cunningham@rmh.nhs.uk.
David
D
Cunningham
St James' Institute of Oncology, Leeds, United Kingdom.
Andrew
A
Jack
University College London, London, United Kingdom.
David
D
Linch
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy*; D008297:Male; D013792:Thalidomide / Q000031:analogs & derivatives*
D007155:Immunologic Factors; D013792:Thalidomide